Avidity Biosciences Stock Analysis

Avidity Stock Analysis Notes

About 95.0% of the company shares are owned by institutional investors. The book value of Avidity Biosciences was at this time reported as 11.03. The company recorded a loss per share of 3.0. Avidity Biosciences had not issued any dividends in recent years. Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California. Avidity Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 125 people. To find out more about Avidity Biosciences contact Sarah Boyce at 858 401 7900 or learn more at https://www.aviditybiosciences.com.

Avidity Biosciences Investment Alerts

Avidity Biosciences Upcoming and Recent Events

Avidity Largest EPS Surprises

View All Earnings Estimates

Avidity Biosciences Environmental, Social, and Governance (ESG) Scores

Avidity Stock Institutional Investors

Note, although Avidity Biosciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Avidity Market Capitalization

The company currently falls under 'Mid-Cap' category with a total capitalization of 4.07 B.

Avidity Profitablity

Management Efficiency

Avidity Biosciences has Return on Asset of (0.2247) % which means that on every $100 spent on assets, it lost $0.2247. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.3419) %, meaning that it generated no profit with money invested by stockholders. Avidity Biosciences' management efficiency ratios could be used to measure how well Avidity Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of July 19, 2025, Return On Tangible Assets is expected to decline to -0.22. The current year's Return On Capital Employed is expected to grow to -0.25. At present, Avidity Biosciences' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 13.2 M, whereas Other Assets are forecasted to decline to 0.86.

Technical Drivers

As of the 19th of July, Avidity Biosciences shows the Mean Deviation of 2.82, downside deviation of 4.59, and Risk Adjusted Performance of 0.1049. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Avidity Biosciences, as well as the relationship between them.

Avidity Biosciences Price Movement Analysis

Avidity Biosciences Insider Trading Activities

Avidity Biosciences Outstanding Bonds

Avidity Biosciences Predictive Daily Indicators

Avidity Biosciences Corporate Filings

Avidity Biosciences Forecast Models

Avidity Biosciences' time-series forecasting models are one of many Avidity Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Avidity Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Avidity Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Avidity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Avidity Biosciences. By using and applying Avidity Stock analysis, traders can create a robust methodology for identifying Avidity entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Avidity analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Avidity analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Avidity Biosciences stock analysis indicators help investors evaluate how Avidity Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Avidity Biosciences shares will generate the highest return on investment. By understating and applying Avidity Biosciences stock analysis, traders can identify Avidity Biosciences position entry and exit signals to maximize returns.

When running Avidity Biosciences' price analysis, check to measure Avidity Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avidity Biosciences is operating at the current time. Most of Avidity Biosciences' value examination focuses on studying past and present price action to predict the probability of Avidity Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avidity Biosciences' price. Additionally, you may evaluate how the addition of Avidity Biosciences to your portfolios can decrease your overall portfolio volatility.